Pruritus News and Research

RSS
Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Meeting

Promising clinical data on CDX-011 in metastatic melanoma presented at ASCO Annual Meeting

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

Mayo Clinic Health Letter: UV light slows skin cell overgrowth, alters immune system

Mayo Clinic Health Letter: UV light slows skin cell overgrowth, alters immune system

Phase III study results of Merck's allergy immunotherapy tablet

Phase III study results of Merck's allergy immunotherapy tablet

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

Health Canada approves Zyclara Cream for multiple actinic keratoses

Health Canada approves Zyclara Cream for multiple actinic keratoses

Incyte's INCB18424 provides previously unachievable clinical benefits in myelofibrosis patients

Incyte's INCB18424 provides previously unachievable clinical benefits in myelofibrosis patients

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Positive results from Phase II clinical trial of INT-747 announced

Positive results from Phase II clinical trial of INT-747 announced

CORD I phase III clinical trial results of XIAFLEX published

CORD I phase III clinical trial results of XIAFLEX published

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

Genentech and Biogen Idec submit applications to FDA for Rituxan in chronic lymphocytic leukemia

Serentis begins trial with first-in-class SRD441 for eczema

Serentis begins trial with first-in-class SRD441 for eczema

Homeopathy in dogs pilot indicates need for larger clinical trial

Homeopathy in dogs pilot indicates need for larger clinical trial

European Commission and US FDA approve intravenous formulation of temozolomide

European Commission and US FDA approve intravenous formulation of temozolomide

Itching after burns - study offers best options

Itching after burns - study offers best options

Pre-emptive treatment helped curtail skin toxicity with Panitumumab

Pre-emptive treatment helped curtail skin toxicity with Panitumumab

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia